Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-226416
Filing Date
2023-08-31
Accepted
2023-08-31 17:18:25
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A d546584ddefa14a.htm DEFA14A 35242
2 GRAPHIC g546584surface.jpg GRAPHIC 7339
  Complete submission text file 0001193125-23-226416.txt   46483
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Filer) CIK: 0001718108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38459 | Film No.: 231229525
SIC: 2836 Biological Products, (No Diagnostic Substances)